Cardiovascular diseases
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients clinically diagnosed with cardiovascular disease and hospitalized in the study departments; 2.Patients who are able to understand the study content and complete questionnaire assessments; 3.Patients who voluntarily agree to participate in the study and provide written informed consent; 4.Patients who are able to cooperate with baseline assessments during hospitalization, collection of relevant objective clinical indicators, biospecimen collection, and long-term post-discharge follow-up;
Exclusion criteria
Exclusion criteria: 1.Patients with end-stage malignant tumors or other serious diseases, with a life expectancy of less than 1 year; 2.Patients with severe cognitive impairment, psychiatric disorders, impaired consciousness, or language/communication disorders that preclude understanding of the study content, completion of questionnaire assessments, or provision of informed consent; 3.Patients in critical condition for whom study-related assessments may substantially increase the patient burden; 4.Patients who have previously participated in other clinical trials that may have intervention conflicts with this study; 5.Other conditions deemed by the investigators to be unsuitable for inclusion in this study;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| All-cause mortality;Major adverse cardiovascular events; | — |
Secondary
| Measure | Time frame |
|---|---|
| Treatment adherence;Quality of life; | — |
Countries
China
Contacts
Fuzhou University Affiliated Provincial Hospital